
“Drugmakers including Bristol-Myers Squibb Co., Pfizer Inc. (PFE) and Eli Lilly & Co. (LLY) have spent billions of dollars on ineffective therapies in a so-far fruitless effort to come up with a treatment for dementia and Alzheimer’s. Now, in the latest of a steady drumbeat of research that suggests diet, exercise and socializing remain patients’ best hope, a study published today in the Proceedings of the National Academy of Sciences shows that vitamins B6 and B12 combined with folic acid slowed atrophy of gray matter in brain areas affected by Alzheimer’s disease.”
Related posts:
Russia Threatens To Dump US Treasurys If Sanctions Imposed
NSA Efforts Damaged U.S. Cryptography Standard
Facebook to pay 614,000 users $15 each over privacy concerns
Glenn Greenwald exposes Obama surveillance to CNN
Gold at a huge premium as Indian imports dry up; survival of small jewellers at stake
Sweden’s deflated economy: Sub-zero conditions
Pennsylvania man pays $7,143 school tax bill in $1 bills
Real life CSI: Google's new AI system unscrambles pixelated faces
FBI repeatedly overstated encryption threat figures to Congress, public
It’s Adapt or Die in the New Saudi Economy
3rd ex-Jackson officer pleads guilty in bribery case
Syrian rebels say they have received anti-tank and anti-aircraft missiles
Drug Agents Use Vast Phone Trove, Eclipsing N.S.A.’s
Florida housing market may get a boost from ‘boomerang buyers’
Police: 13-year-old took $25K, passed out $100 bills to classmates